New Hope for Liver Fibrosis Treatment

from TheBrief.Health · host TheBrief.Health

McMaster researchers report EVT0185 may prevent and reverse liver fibrosis by targeting metabolism, offering a promising therapy for MASH with clinical trials expected by 2027.

Episode metadata supplied by the publisher feed · Published Jan 14, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

New Hope for Liver Fibrosis Treatment

0:00 1:37

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TheBrief.Health?

This episode is 1 minute long.

When was this TheBrief.Health episode published?

This episode was published on January 14, 2026.

Can I download this TheBrief.Health episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!